Fluphenazine Tablets
Form: Oral Tablets
Strength: 1 mg, 2.5 mg, 5 mg, 10 mg
Reference Brands: Prolixin®(US); Modecate®(EU)
Category: Antipsychotropic Drugs
Fluphenazine tablets are FDA-approved in the United States for the treatment of schizophrenia and other chronic psychotic disorders. In the European Union, they are available in select countries via national authorizations. Regulatory requirements include GMP-compliant manufacturing, clinical safety data addressing extrapyramidal symptoms, and adherence to FDA and EMA psychiatric labeling standards. U.S. filings must comply with NDA or ANDA guidelines, including bioequivalence data. EU submissions may require bridging studies and updated pharmacovigilance plans. To explore dossier-ready Fluphenazine tablets, alternate forms, and verified suppliers, visit Pharmatradz.com — your global B2B platform for pharmaceutical sourcing.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details Get Enquiry
Zuclopenthixol ong-acting IM Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details Get Enquiry
Zuclopenthixol tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details Get Enquiry